U.S. Professional Services Stock News

Stock performance snapshot Park National (PRK) has drawn attention after recent share price moves, with the stock showing a mix of short term weakness and longer term gains that may prompt investors to reassess its latest financial profile. Over the past day, Park National’s share price reflected a 1.4% decline, adding to a 5.6% fall over the past week. By contrast, the stock shows a small gain over the past month and the past 3 months. For longer term holders, the picture is more mixed. The...

In recent weeks, Chord Energy has faced mixed analyst sentiment, with Citi downgrading the stock while other firms maintained more favorable ratings amid sector-wide macro concerns. At the same time, Chord Energy moved to expand its Williston Basin footprint through a US$550 million purchase of Exxon Mobil’s XTO Energy assets, signaling a material shift in its asset base and cash flow profile. We’ll now examine how this XTO Energy asset acquisition shapes Chord Energy’s investment narrative...

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.

As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.

Elevance Health (ELV) closed out FY 2025 with Q4 revenue of US$49.7b and basic EPS of US$2.47, alongside net income of US$547m. Over the past six quarters, the company has seen quarterly revenue move from US$45.1b in Q3 2024 to a range between US$48.9b and US$50.7b through 2025, while quarterly EPS shifted from US$4.38 to US$9.64 and then to US$2.47. This sets up an earnings print where margin resilience is front of mind for investors. See our full analysis for Elevance Health. With the...

Why the Renergen Helium Project Update Matters for ASP Isotopes (ASPI) ASP Isotopes (ASPI) has given investors a detailed production update on the newly acquired Renergen Helium Project, outlining higher gas throughput, completed plant upgrades, and a timetable toward positive operational cash flow before the end of 2026. See our latest analysis for ASP Isotopes. The Renergen update lands after a volatile stretch, with a 1-day share price return of 1.93% and a 7-day move of 8.77% helping...

Why Vaxart’s Norovirus Data Matters for Investors Vaxart (VXRT) has drawn fresh attention after npj Vaccines published Phase 1 data on its single dose, oral bivalent norovirus vaccine in postpartum, breastfeeding women, highlighting immune responses in both mothers and their infants. See our latest analysis for Vaxart. The new npj Vaccines publication comes after a strong 30 day share price return of 83.38% and 90 day share price return of 81.95%. However, the 1 year total shareholder return...

Curious whether Broadridge Financial Solutions at around US$204.89 is offering fair value or a potential bargain right now? This article walks through the numbers in a clear way so you can judge for yourself. The stock has seen mixed returns, with a 0.9% decline over the last 7 days, a 9.9% decline over the last 30 days and a 7.1% decline year to date. The 3 year and 5 year returns sit at 40.4% and 54.1% respectively, and the 1 year return is a decline of 11.6%. Recent coverage has focused...

First Busey (BUSE) has put a fuller year of numbers on the table for FY 2025, with fourth quarter revenue of US$197.8 million and EPS of US$0.63, rounding out trailing twelve month revenue of US$666.8 million and EPS of US$1.49. The company has seen revenue move from US$453.7 million and EPS of US$2.01 on a trailing basis in late 2024 to US$666.8 million and EPS of US$1.49 by the end of 2025. This is setting up a results season where investors are weighing those headline figures against a...

Travel + Leisure Co. has opened its new global headquarters at 501 W. Church St. in Downtown Orlando, relocating more than 900 associates and investing over US$36 million in a hybrid-friendly, wellness-focused workplace. The move deepens the company’s ties to Orlando’s urban core while expanding community engagement through the Travel + Leisure Charitable Foundation and local partnerships. We’ll now examine how this Orlando headquarters investment, especially its focus on a modern hybrid...

If you are wondering whether Corteva's current share price still offers value, it helps to step back and look at what the recent numbers and valuation checks are actually saying. Corteva's share price last closed at US$73.05, with returns of 2.2% over 7 days, 8.0% over 30 days, 7.8% year to date, 13.5% over 1 year and 17.2% over 3 years, plus 84.4% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation. Recent news around Corteva has...

If you are wondering whether Icahn Enterprises at a last close of US$7.74 offers genuine value or just headline risk, you are not alone. This article is built to help you weigh that up clearly. The stock has been mixed recently, with a 6.0% return over 30 days and a 3.5% return year to date, set against a 2.4% decline over 1 year and much steeper 3 year and 5 year returns of 73.1% and 67.3% declines. These moves sit in the shadow of earlier scrutiny of Icahn Enterprises' structure and short...

In recent days, Travere Therapeutics disclosed that the FDA classified additional data for its FILSPARI sNDA as a major amendment, extending the review timeline and setting a new PDUFA action date of April 13, 2026, while multiple law firms announced investigations into potential securities law violations related to the company’s disclosures. This combination of a lengthened regulatory path for a key rare-disease therapy and parallel securities investigations adds an extra layer of...

Houlihan Lokey (NYSE:HLI) has expanded its European footprint with the hire of Mark Ward as Managing Director to lead IT Services coverage. The firm has also completed acquisitions in European real estate and corporate finance, adding sector depth and local capabilities. These moves reflect an active push to grow both organically and through acquisitions in key European markets. At a share price of $180.53, Houlihan Lokey has delivered a 3 year return of 94.8% and a 5 year return of 199.2%...

In January 2026, First Horizon Corporation raised its quarterly common dividend to US$0.17 per share and declared regular cash dividends on several preferred stock series, with payments scheduled in April and May 2026 to shareholders of record in March and April. The combination of higher common payouts and continued preferred dividends highlights management’s confidence in the bank’s earnings capacity following stronger fourth-quarter 2025 results. We’ll now examine how the higher common...

Certara (CERT) is back on investors’ radar after Meridian Growth Fund flagged the stock as a relative detractor, citing weaker-than-expected Q4 2025 service bookings and a modest guidance cut. See our latest analysis for Certara. At a share price of $9.40, Certara has seen a 6.21% 1 month share price return but a 17.25% 3 month share price decline. Its 1 year total shareholder return of 32.33% and 5 year total shareholder return of 73.68% point to pressure building over longer periods as...

What Recent Performance Says About PotlatchDeltic PotlatchDeltic (PCH) has drawn investor attention after a mix of short term weakness and modest recent gains, with the share price down over the past week but up over the past month and past 3 months. See our latest analysis for PotlatchDeltic. That mix of near term weakness and recent gains fits a broader pattern, with the 30 day share price return of 3.78% and year to date share price return of 4.31% sitting against a 1 year total...

If you are wondering whether Hilton Worldwide Holdings at around US$296 per share still offers value, or if most of the upside is already reflected in the price, this article is for you. The stock has been relatively steady over the short term, with a 0.1% decline over 7 days, a 1.4% return over 30 days, and returns of 1.1% year to date, 17.0% over 1 year, 102.9% over 3 years, and 181.4% over 5 years. Recent news coverage has focused on Hilton's position as a major global hotel operator and...

National Fuel Gas (NYSE:NFG) disclosed a significant increase in CEO compensation in a recent SEC filing. The company also announced new government contract awards, expanding its role as an energy supplier to public sector customers. These developments update investors on executive pay structures and newly secured business commitments. National Fuel Gas, traded as NYSE:NFG, operates across natural gas exploration, production, gathering, and utility services. For you as a shareholder or...

Recently, sector-wide concerns emerged after UnitedHealth Group issued a cautious revenue outlook, outlined major restructuring plans, and flagged pressure from proposed flat Medicare Advantage payment rates, weighing on peers such as Privia Health Group. This reaction came even though Privia Health had earlier highlighted strong Accountable Care Organization Medicare shared savings and increased its 2025 Adjusted EBITDA guidance, which had been viewed positively by analysts. Next, we will...

If you are wondering whether Nova's recent share price puts it at a premium or leaves some value on the table, this article will walk through what the current numbers are saying about the stock. Nova's share price recently closed at US$487.18, with returns of 5.2% over 7 days, 45.9% over 30 days, 40.3% year to date and 109.6% over 1 year, while the 3 year return is over 4x and the 5 year return is very large. Recent coverage has focused on how Nova fits into the semiconductor equipment space...